Revance Therapeutics | DETTE

Name: Revance Therapeutics | DETTE
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Debt		Date
Abbvie ABBV:US	$ 86056M	1003M	2020-12
Adamas Pharmaceuticals ADMS:US	$ 129.96M	0.16M	2020-12
Aerie Pharmaceuticals AERI:US	$ 210.37M	5.68M	2020-12
ALKERMES ALKS:US	$ 274.96M	0.55M	2020-12
Biodelivery Sciences International BDSI:US	$ 78.36M	0.09M	2020-09
Bristol Myers Squibb BMY:US	$ 50676M	5727M	2020-12
Cara Therapeutics CARA:US	$ 0	0	2020-12
Coherus Biosciences CHRS:US	$ 405.46M	0.9M	2020-12
Eli Lilly And LLY:US	$ 16595.3M	326.8M	2020-12
Endo International Ordinary Shares ENDP:US	$ 8345.98M	7.22M	2020-12
Flexion Therapeutics FLXN:US	$ 221.05M	2.6M	2020-09
Gw Pharmaceuticals GWPH:US	$ 15.3M	0.66M	2020-12
Horizon Pharma HZNP:US	$ 1003.38M	0.53M	2020-12
JAZZ PHA JAZZ:US	$ 2094.84M	7.15M	2020-12
Johnson & Johnson JNJ:US	$ 35266M	2492M	2020-12
Merk MRK:US	$ 31791M	3050M	2020-12
Neurocrine Biosciences NBIX:US	$ 317.9M	107.1M	2020-12
Pacira Pharmaceuticals PCRX:US	$ 462.68M	6.21M	2020-12
Procter & Gamble PG:US	$ 31100M	555M	2020-12
Revance Therapeutics RVNC:US	$ 180.53M	3.15M	2020-12
Teva Pharmaceutical Industries TEVA:US	$ 25919M	298M	2020-12
Zogenix ZGNX:US	$ 149.35M	21.39M	2020-12

Revance Therapeutics DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2021.